Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ABOS | AZN | AMGN | GILD | VRTX |
| Company | Acumen Pharmaceuticals Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.9200 | 91.18 | 316.25 | 119.49 | 438.81 |
| High | 1.9550 | 91.30 | 316.97 | 120.66 | 441.03 |
| Low | 1.8800 | 89.70 | 313.00 | 118.78 | 433.81 |
| Latest | 1.9000 | 90.74 | 315.67 | 120.47 | 438.98 |
| Change | -0.0500 | +0.92 | +1.82 | +1.11 | +1.97 |
| % Change | -2.56% | +1.02% | +0.58% | +0.93% | +0.45% |
| Volume | 40,741 | 3,838,741 | 1,098,832 | 2,470,153 | 354,299 |
| 20-Day Average Volume | 155,411 | 5,454,053 | 2,841,271 | 6,918,002 | 1,362,315 |
| Previous Close | 1.9500 | 89.82 | 313.85 | 119.36 | 437.01 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.8043 | 90.37 | 335.93 | 124.41 | 435.83 |
| 20-Day Raw Stochastic | 73.15% | 51.14% | 8.65% | 15.37% | 42.54% |
| 20-Day Relative Strength | 51.16 | 58.90 | 46.67 | 46.84 | 54.03 |
| Weighted Alpha | +7.20 | +39.67 | +16.63 | +27.61 | -2.79 |
| Today's Opinion | 56% Buy | 100% Buy | 72% Buy | 56% Buy | 24% Buy |
| Previous Opinion | 72% Buy | 88% Buy | 72% Buy | 56% Buy | 24% Buy |
| Last Month's Opinion | 88% Buy | 100% Buy | 56% Buy | 88% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.81% since 12/03/25 | -0.17% since 12/03/25 | -8.52% since 12/03/25 | -3.76% since 12/03/25 | -5.47% since 12/03/25 |
| Low | 1.8500 on 12/08/25 | 89.67 on 12/08/25 | 313.10 on 12/10/25 | 118.78 on 12/10/25 | 433.92 on 12/10/25 |
| High | 2.0200 on 12/05/25 | 91.44 on 12/09/25 | 346.33 on 12/04/25 | 124.96 on 12/04/25 | 463.70 on 12/04/25 |
| 1-Month | |||||
| %Chg | +0.26% since 11/10/25 | +3.68% since 11/10/25 | -2.37% since 11/10/25 | +1.82% since 11/10/25 | +3.94% since 11/10/25 |
| Low | 1.5000 on 11/17/25 | 87.23 on 11/12/25 | 313.10 on 12/10/25 | 118.58 on 11/11/25 | 417.12 on 11/11/25 |
| High | 2.0400 on 11/12/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +40.37% since 09/10/25 | +12.24% since 09/10/25 | +13.45% since 09/10/25 | +4.39% since 09/10/25 | +12.68% since 09/10/25 |
| Low | 1.2100 on 09/16/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 2.4600 on 10/28/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +60.59% since 06/10/25 | +22.85% since 06/10/25 | +7.68% since 06/10/25 | +9.28% since 06/10/25 | -3.04% since 06/10/25 |
| Low | 1.0500 on 06/16/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 2.4600 on 10/28/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 118,117 | 278,570,080 | 169,002,272 | 148,087,568 | 110,877,744 |
| Shares Outstanding, K | 60,573 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -102,330,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -26,450,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.25 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.44 on 11/12/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/26/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 11/21/25 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.97 | 14.69 | 14.80 | 28.87 |